Viewing nowCombinationExcombi Tab 5/80mg
Amlodipine Besylate 6.94mg · Valsartan 80mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.

MFDS item code 201308573 · Approved 2013.07.31 · Insurance code 671805580
Treatment of essential hypertension not adequately controlled with monotherapy
This medication is prescribed for patients with essential hypertension whose blood pressure is not sufficiently controlled by Amlodipine or Valsartan alone. Essential hypertension can put stress on the heart and blood vessels, so it is important to effectively lower blood pressure. This medication helps to manage blood pressure reliably with a combination of two components. This can reduce the risk of cardiovascular complications and maintain a healthy condition. Therefore, it is used in the treatment of essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before this medicine is administered. However, if blood pressure is not controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Those with allergies to this medication's main ingredients or similar class medications, pregnant or lactating women, and patients with severe kidney or liver diseases should not take this medication. Patients with low sodium or fluid levels in the body may experience hypotension, so it is important to check their conditions before taking the medication and monitor blood pressure closely during use. Patients with high potassium levels may experience an increase in potassium levels when taking this medication with potassium-containing drugs or supplements, so regular blood tests are necessary. Patients with vascular issues in the kidneys or those who have recently received a kidney transplant should use this medication with caution due to the risk of worsening kidney function. This medication can cause a rare side effect called angioedema. If swelling of the face or neck occurs, or if breathing difficulties arise, the medication should be discontinued immediately and medical attention sought. Patients with heart failure or after myocardial infarction should monitor kidney function and blood pressure periodically while taking this medication, and acute myocardial infarction patients should use it with caution. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. There may be interactions with other antihypertensive medications, potassium supplements, and certain NSAIDs, so if there are other medications being taken, it is essential to inform the doctor or pharmacist. Pregnant women or those planning to become pregnant should not use this medication, and breastfeeding women should also avoid it. Safety and effectiveness in patients under 18 years of age have not been established, and use in children is not recommended. Overdose may cause dizziness and severe hypotension, so it is important to adhere strictly to the prescribed dosage, and if abnormal symptoms occur, seek medical attention immediately. During the use of this medication, it is necessary to regularly check blood pressure, kidney function, and electrolyte levels, and consult a healthcare professional if any unusual symptoms appear.
Pharyngitis, Influenza, Hypersensitivity, Visual impairment, Anxiety, Headache, Dizziness, Drowsiness, Orthostatic dizziness, Paresthesia, Lightheadedness, Tinnitus, Tachycardia, Palpitations, Syncope, Orthostatic hypotension, Hypotension, Cough, Pharyngeal and laryngeal pain, Diarrhea, Nausea, Abdominal pain, Constipation, Dry mouth, Rash, Erythema, Hyperhidrosis, Itching, Joint swelling, Low back pain, Arthritis, Muscle spasms, Lethargy, Polyuria, Nocturia, Erectile dysfunction, Edema, Peripheral edema, Facial edema, Generalized edema, Fatigue, Flushing, Weakness, Facial flushing, Decreased hemoglobin, Decreased hematocrit, Neutropenia, Thrombocytopenia, Serum sickness including hypersensitivity, Increased serum potassium, Vasculitis, Elevated liver function tests, Angioedema, Myalgia, Renal failure, Kidney damage, Increased serum creatinine, Insomnia, Decreased libido, Pharyngitis, Rhinitis, Sinusitis, Upper respiratory infection, Viral infection, Intestinal vascular edema, Diplopia, Thrombocytopenia, Leukopenia, Allergic reaction, Hyperglycemia, Insomnia, Mood changes, Tremors, Sensory impairment, Dysgeusia, Peripheral neuropathy, Muscle rigidity, Arrhythmia, Bradycardia, Atrial fibrillation, Ventricular tachycardia, Myocardial infarction, Vasculitis, Shortness of breath, Rhinitis, Vomiting, Dyspepsia, Pancreatitis, Gastritis, Gingival hyperplasia, Hepatitis, Jaundice, Alopecia, Purpura, Skin depigmentation, Photosensitivity reaction, Angioedema, Urticaria, Erythema multiforme, Stevens-Johnson syndrome, Myalgia, Urinary disorder, Nocturnal enuresis, Gynecomastia, Pain, Malaise, Chest pain, Weight loss, Weight gain, Elevated liver enzymes, Chest discomfort, Abdominal discomfort, Gastroesophageal reflux disease, Neck pain, Hypercholesterolemia, Hypoglycemia, Nervousness, Stevens-Johnson syndrome, Chest pain, Weight gain, Arthralgia, Skeletal pain, Rhabdomyolysis, Gingival dysplasia, Gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container to protect it from air and moisture, and it is advisable to store it at room temperature between 1 degree and 30 degrees. Storing in this way will ensure the safety of the medication's efficacy.
Dark yellow round film-coated tablet
Domestic use: 30 tablets (10 tablets/PTP X 3), Export use: 30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.